Latest filing published 14 Aug 2026 for Optomed Oyj.
No signal scores available.
Catherine Calarco, listed as board member, appears in our data through filings on Optomed Oyj shares, published by Nasdaq Helsinki. Over a trading history stretching from 7 August 2023 to 13 August 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 August 2026: a transaction, in Optomed Oyj. Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Nasdaq Helsinki. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations